some discontinued due to side effects or lack of response
135 min gradient) and acquired in DDA mode (MS1: 3502000 m/z, followed by MS/MS)
Insulin used more efficiently better metabolic health supports glucose uptake and blood sugar control
Oral capsules, powder, and transdermal/DMSO preparations are all in community use, with ongoing debate about absorption
The most common presenting symptoms are weight loss, weakness, dyspnea, palpitations, increased thirst or appetite, diarrhea, irritability, profuse diaphoresis, heat intolerance and increased tolerance to cold, or tremor
They are pathway-level markers not predictors of how you will respond to a given drug, but a description of the metabolic terrain any prescription enters